Log In
BCIQ
Print this Print this
 

IVIG

  Manage Alerts
Collapse Summary General Information
Company ProMetic Life Sciences Inc.
DescriptionIntravenous immunoglobulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentIND
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today